Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Cash Flow Quality Index
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Quality Index of 2.22x as of December 2025. Operating cash flow of CN¥22.41 Million exceeds net income of CN¥10.09 Million, indicating high earnings quality where cash backs reported profits. Also explore 688193 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Rendu Biotechnology Co. Ltd. A (688193) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year earnings quality comparison for Shanghai Rendu Biotechnology Co. Ltd. A. For live market cap and the full company financial profile, see 688193 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.22x | CN¥22.41 Million | CN¥10.09 Million | ▲ +6.7% |
| 2023 | 2.08x | CN¥17.19 Million | CN¥8.26 Million | ▲ +1287.0% |
| 2022 | -0.18x | CN¥-4.09 Million | CN¥23.33 Million | ▼ -120.8% |
| 2021 | 0.84x | CN¥54.44 Million | CN¥64.62 Million | ▼ -44.2% |
| 2020 | 1.51x | CN¥92.61 Million | CN¥61.38 Million | ▼ -58.7% |
| 2019 | 3.65x | CN¥13.67 Million | CN¥3.74 Million | — |